Entering text into the input field will update the search result below

Depomed beats by $0.07, beats on revenue

  • Depomed (DEPO): Q3 EPS of $0.03 beats by $0.07.
  • Revenue of $51.49M (+37.5% Y/Y) beats by $10.02M.
  • Press Release

Recommended For You

More Trending News

About ASRT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ASRT--
Assertio Holdings, Inc.